Navigation Links
Gene Variations May Predict Antidepressant Response
Date:7/18/2008

Finding could help advance individualized medicine for psychiatric patients

FRIDAY, July 18 (HealthDay News) -- Scientists may have found more evidence that a person's genetic make-up may help determine whether or not they respond to the antidepressant Celexa (citalopram).

Specifically, researchers at the Mayo Clinic have found that variations in the serotonin transporter gene could help select which patients should try this drug, one of the family of medications known as selective serotonin reuptake inhibitors (SSRIs).

Some 10 percent of the American population now take antidepressants, making it the most widely prescribed drug class in the country.

But finding the right antidepressant can be a painful, trial-and-error approach, with physicians not knowing which drug is right for which patient until they've actually tried it.

"Patients want to feel better as quickly as possible, so the idea of trying one drug after another until you find one that works can be discouraging. The development of pharmacogenetic testing will help increase the likelihood of selecting an effective drug the first time," study senior author Dr. V. David Mrazek, chairman of the Mayo Clinic's department of psychiatry and psychology, said in a clinic news release. Mrazek is also director of the Clinic's Genomic Expression and Neuropsychiatric Evaluation (GENE) Unit.

Mrazek and his colleagues looked at the serotonin transporter gene, SLC6A4, in about 2,000 individuals.

White patients who had two variations of the gene were more likely to get help from Celexa. There appeared to be no link between the two variations and the odds of remission in black or Hispanic patients.

"The findings of this study represent another step in advancing individualized medicine for psychiatric patients," Mrazek said.

The study was published in the current issue of the American Journal of Medical Genetics Part B: Neuropsychiatric Genetics.

More information

The National Institute of Mental Health has more on depression.



-- HeathDay Staff



SOURCE: Mayo Clinic, news release, July 14, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Study shows gene variations may predict risk of breast cancer in women
2. Genetic variations raise lung cancer risk for smokers and ex-smokers
3. New report highlights variations in approaches to thoracic surgery in the United Kingdom and Ireland
4. Study Finds Variations in Doses of Radiation Therapy
5. More Gene Variations Found That Raise Prostate Cancer Risk
6. Study questions impact of hemoglobin variations on mortality in dialysis patients
7. Optherion Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostics Based on Chromosome 10 Genetic Variations
8. Climatic variations influence the emergence of cholera in Africa
9. New research from Rhode Island Hospital may help predict outcomes for stomach cancer patients
10. NOAA and Louisiana scientists predict largest Gulf of Mexico dead zone on record
11. Recent Genetic Discoveries Dont Improve Prediction of Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
(Date:6/23/2016)... Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new ... affiliate in Latin America . ... ... ... ...
Breaking Medicine Technology: